Ginkgo Bioworks Holdings (DNA) Accounts Payables (2020 - 2026)

Ginkgo Bioworks Holdings (DNA) has reported Accounts Payables for 7 consecutive years, with $9.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Accounts Payables fell 14.52% year-over-year to $9.6 million; the trailing twelve-month figure through Jun 2026 stood at $9.6 million (down 14.52% YoY), and the FY2025 full-year result was $10.6 million, down 25.43% from the prior year.
• Accounts Payables fell to $9.6 million in Q2 2026 per DNA's latest filing, from $16.3 million in the prior quarter.
• Across five years, Accounts Payables topped out at $35.3 million in Q1 2022 and bottomed at $9.3 million in Q4 2023.
• Historically, Accounts Payables has averaged $15.6 million across 5 years, with a median of $12.5 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Accounts Payables soared 2379.71% in 2022, then sank 58.26% in 2025.
• Over 5 years, Accounts Payables stood at $10.5 million in 2022, then fell by 10.79% to $9.3 million in 2023, then surged by 51.98% to $14.2 million in 2024, then decreased by 25.43% to $10.6 million in 2025, then slipped by 9.38% to $9.6 million in 2026.
• According to Business Quant data, Accounts Payables over the past three periods registered $9.6 million, $16.3 million, and $10.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.